Fortis Hospitals, India Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT00814372
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fortis CDOC Hospital | Fortis FLT.LT.Rajan Dhall Hospital ,New Delhi, India | Fortis Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Foot (Phase 2)

Fibrosis (Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 2)

Ischemia (Phase 2)

Leg Ulcer (Phase 2)

Pulmonary Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 8